Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice

Gene Therapy

Volumn 6, Issue 1, 1999, Pages 121-129

  Nomura, T ^a   Yasuda, K ^a   Yamada, T ^a   Okamoto, S ^a   Mahato, R I ^a,b   Watanabe, Y ^a   Takakura, Y ^a   Hashida, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b GeneMedicine Inc   (United States)

Author keywords

DC chol liposome; Gene therapy; Interferon ; Intratumoral injection; Naked plasmid DNA

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; LIPOSOME; LUCIFERASE; PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER REGRESSION; COLON TUMOR; COMPLEX FORMATION; CONTROLLED STUDY; DNA ADDUCT; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GENE TRANSFER; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; CYTOKINES; DNA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; LIPOSOMES; LUCIFERASES; MICE; MUSCLE, SKELETAL; NEOPLASMS; PLASMIDS;

ANIMALIA;

EID: 0032931559     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300792     Document Type: Article

References (48)

1. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967.
2. Sun WH et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 1995; 92: 2889-2893.
3. Plautz GE et al. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 1993; 90: 4645-4649.
4. Addison CL et al. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci USA 1995; 92: 8522-8526.
5. Ido A et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res 1995; 55: 3105-3109.
6. Kimura O et al. Retroviral delivery of DNA into the liver of transgenic mice bearing premalignant and malignant hepatocelluar carcinomas. Hum Gene Ther 1994; 5: 845-850.
7. Wei MX et al. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 1995; 6: 437-443.
8. Toloza EM et al. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther 1996; 3: 11-17.
9. Hallahan DE et al. Spacial and temporal control of gene therapy using ionizing radiation. Nature Med 1995; 1: 786-791.
10. Cordier L et al. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Therapy 1995; 2: 16-21.
11. Caruso M et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 1996; 93: 11302-11306.
12. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
13. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Therapy 1995; 2: 710-722.
14. Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotech 1997; 15: 167-173.
15. Templeton NS et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression. Nature Biotech 1997; 15: 647-652.
16. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 1991; 179: 280-285.
17. Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
18. Bebok Z et al. Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro. J Pharmacol Exp Ther 1996; 279: 1462-1469.
19. Egilmez NK, Iwanuma Y, Bankert RB. Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem Biophys Res Commun 1996; 221: 169-173.
20. Nabel GJ et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
21. Nabel GJ et al. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA 1996; 93: 15388-15393.
22. Yang JP, Huang L. Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Therapy 1996; 3: 542-548.
23. Nomura T et al. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res 1997; 57: 681-2686.
24. Baron S et al. Introduction to the interferon system. In: Baron S, Coppenhaver DH, Dianzani F (eds). Interferon, Principles and Medical Applications. University of Texas: Galveston, TX, 1992, pp 1-15.
25. Watanabe Y et al. Exogenous expression of mouse interferon-γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augumented anti-tumor immunity. Proc Natl Acad Sci USA 1989; 86: 9456-9460.
26. Watanabe Y, Sakata T. Highly efficient action of aoutocrine mouse interferon-γ expressed via a retroviral vector. Eur J Immunol 1988; 18: 1627-1630.
27. Gansbacher B et al. Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long-lasting antitumor immunity. Cancer Res 1990; 50: 7820-7825.
28. Abdel-Wahab Z et al. A phase 1 clinical trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells. Cancer 1997; 80: 401-412.
29. Wolff JA et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
30. Danko I et al. Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum Mol Genet 1993; 2: 2055-2061.
31. Wolff JA et al. Expression of naked plasmids by cultured myotubes and entry of plasmids into T-tubes and caveolae of mammalian skeletal muscle. J Cell Sci 1993; 103: 1249-1259.
32. Naffakh N et al. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther 1996; 7: 11-21.
33. Levy MY, Barron LG, Meyer KB, Szoka Jr. FC. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Therapy 1996; 3: 201-211.
34. Hickman MA et al. Hepatic gene expression after direct DNA injection. Adv Drug Del Rev 1995; 17: 265-271.
35. Schwarts B et al. Gene transfer by naked DNA into adult mouse brain. Gene Therapy 1996; 3: 405-411.
36. Egilmez NK et al. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Gene Therapy 1996; 3: 607-614.
37. Boulikas T. Nuclear localization signal peptides for the import of plasmid DNA in gene therapy. Int J Oncol 1997; 10: 301-309.
38. Vassalli-P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-452.
39. Mario CF, Nigel CP. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1997; 1329: 345-356.
40. Kawabata K et al. A physiological role of interferon (IFN)-β derived from tumor: tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-β. Cancer Lett 1997; 113: 159-164.
41. Yagi K et al. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain. Biochem Mol Biol Int 1994; 32: 167-171.
42. Stewart WE, Gosser LB, Lockart RZ. Priming: a nonantiviral function of interferon. J Virol 1971; 7: 792-801.
43. Kelley KA, Pitha PM. Differential effect of poly rI.rC and newcastle virus on the expression of interferon and cellular genes in mouse cells. Virology 1985; 147: 382-393.
44. Wicks IP et al. Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. Hum Gene Ther 1995; 6: 317-323.
45. Roman M et al. Immunomodulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med 1997; 3: 849-854.
46. Kawabata K et al. Non-polarized secretion of mouse interferon-β from gene-transferred human intestinal Caco-2 cells. Pharm Res 1997; 14: 483-485.
47. Kawade Y, Watanabe Y. Characterization of rat monoclonal antibodies to mouse Interferon-α and β. In: Cantell K, Schellekens H (eds). The Biology of the Interferon System. Nijhoff: Dordrecht, 1987, pp 197-201.
48. Spitalny GL, Havell EA. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 1984; 159: 1560-1565.